Piper Jaffray Remains Bullish on Illumina (ILMN) Following EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Janney Capital Downgrades Illumina (ILMN) to Neutral
July 22, 2015 8:08 AM EDTJanney Capital downgraded Illumina (NASDAQ: ILMN) from Buy to Neutral with a price target of $240 (unchanged).
For an analyst ratings summary and ratings history on Illumina click here. For more ratings news on Illumina click here.
Shares of Illumina closed at $237.54 yesterday.
... MoreMizuho Securities Raised Price Target on Illumina (ILMN) Following EPS Beat
July 22, 2015 7:30 AM EDTMizuho Securities maintained a Buy rating on Illumina (NASDAQ: ILMN), and raised the price target to $240.00 (from $230.00), ILMN reported EPS of $0.80, beating consensus by 3c. Analyst Peter Lawson said that he would be a buyer on any weakness.
Lawson commented, "We... More
After-Hours Stock Movers 07/21: (ISRG) (NUAN) (GPRO) Higher; (ILMN) (EXEL) (AAPL) Lower (more...)
July 21, 2015 5:31 PM EDTIntuitive Surgical (NASDAQ: ISRG) 13.3% HIGHER; reported Q2 EPS of $4.57, $0.59 better than the analyst estimate of $3.98. Revenue for the quarter came in at $586.1 million versus the consensus estimate of $566.86 million.
Illumina (NASDAQ: ILMN) 11.6% LOWER; reported Q2 EPS of $0.80, $0.03 better than the analyst estimate of $0.77. Revenue for the quarter came in at $539 million versus the consensus estimate of $541.77 million. Illumina sees FY2015 EPS of $3.39-$3.45, versus the consensus of $3.44.
Exelixis, Inc. (Nasdaq:... More
Illumina (ILMN) Tops Q2 EPS by 3c; Updates FY15 EPS Outlook
July 21, 2015 4:09 PM EDTIllumina (NASDAQ: ILMN) reported Q2 EPS of $0.80, $0.03 better than the analyst estimate of $0.77. Revenue for the quarter came in at $539 million versus the consensus estimate of $541.77 million.
Illumina sees FY2015 EPS of $3.39-$3.45, versus the consensus of $3.44.
For earnings history and earnings-related data on Illumina (ILMN) click here.
... MoreIllumina (ILMN) Appoints New SVP
July 20, 2015 4:20 PM EDTIllumina (NASDAQ: ILMN) announced that Sanjay Chikarmane has been named Senior Vice President and General Manager of Illuminas Enterprise Informatics business. Chikarmane will lead the development and commercialization of products and services aimed at turning genomic data into actionable information for researchers and clinicians. He will report to Illumina President, Francis deSouza.
Given the growing data intensive demands of the... More
